Results of radiation therapy in early glottic carcinoma (T1 T2 N0)
β Scribed by Dr. Moshe Stein; Edward Rosenblatt; Abraham Kuten; Dr. Yoram Cohen
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 415 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Glottic carcinoma is curable by either surgery or radiotherapy. A total of 60 patients were treated by radiation alone at the Northern Israel Oncology Center, Rambam Medical Center, Haifa, between 1970 and 1980. Twentynine (48%) were classified as TI No and 31 (52%) as T2 No. All patients received radiotherapy primarily with curative intent, with surgery reserved for recurrences. The 5-year actuarial survival for all patients was 90% and actuarial disease-free survival was 95%. In ten patients (17%) there was local failure, and five of them were salvaged by surgery. There were no significant acute or long-term complications of radiation. Factors influencing treatment outcome (anterior commissures involvement, degree of differentiation, treatment volume, and technique of irradiation) and the occurrence of second primary malignancies are discussed.
π SIMILAR VOLUMES
## Abstract ## Introduction This new prospective clinical study assessed the oncological outcomes following surface illumination mTHPCβphotodynamic therapy of T1/T2 N0 oral squamous cell carcinoma (OSCC) patients. ## Material/Methods Thirtyβeight patients participated in this study. Their mean a
## Abstract ## Background. Laser cordectomy for glottic cancer is still hampered by recurrence, which is more frequent upon anterior commissure (AC) involvement. Analysis of results may be a step to improve the efficacy of this therapy for early glottic cancer. ## Methods. In all, 81 patients wh
## Background: The appropriate treatment approach for patients with t2n0 laryngeal cancer remains highly controversial. because radiotherapy alone is associated with a high risk of local recurrence, we have developed a triple combination treatment approach consisting of 5-fluorouracil (250 mg/day,
## Background: The best therapeutic approach for the treatment of stage ii (t2n0m0) glottic carcinoma is controversial. ## Methods: A retrospective tumor registry data retrieval of patients with stage ii glottic carcinoma treated with curative intent at washington university medical center-barnes
## Abstract ## Background. Carcinoma of the larynx is the most common cancer affecting the head and neck region. In Northern Europe, early laryngeal cancer is almost universally treated by irradiation, but elsewhere it is treated by surgery. The main aim of this study was to determine whether ther